Japan’s Olympus Corp. is synonymous with cameras.
From its earliest camera in 1936, Olympus built a reputation for quality and innovation, such as its 1971 model 35DC, the world’s first camera with an automatic flash. Yet that storied legacy came to an end in January, when Olympus finalized the sale of its camera and voice recorder businesses to Tokyo-based private equity firm Japan Industrial Partners for an undisclosed amount. “I have [had] a longtime ambition to really change this company,” says president and CEO Yasuo Takeuchi in an interview at the company’s Tokyo headquarters.
It was a bold shedding of a signature business built up over eight decades. Without cameras, what’s next for Olympus? Takeuchi’s answer: “We have a very good business on the medical side.” Takeuchi is now overseeing Olympus’ most extensive corporate makeover in its 102-year history, with the aim to create a pure-play medical technology (medtech) giant.
This pivot takes Olympus back to its roots. While renowned for its cameras, Olympus has a long and parallel history in medical technology, using its optical expertise to make microscopes and endoscopes. In fact, the first product released by Olympus was a microscope, launched just six months after the company’s founding in 1919. Then came endoscopes—Olympus created in 1950 what it dubbed a “gastrocamera,” a device, while rudimentary, laid the basis for modern endoscopes.
Olympus says it is the world’s largest maker of gastrointestinal end scopes, commanding 70% of the $3.3 billion global market.
This story is from the October 2021 edition of Forbes Indonesia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the October 2021 edition of Forbes Indonesia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
BACK ON TRACK
Collective wealth gets a 21% boost to a record $162 billion amid an economic uptick.
Championing Locals
The wave of social commerce is enabling inclusive digital economies beyond urban areas.
Boys in the Bubble
Startups are supposed to specialize, but OPENSEA’s founders thrived by building a wide-open market for creating and trading all manner of NFTs, whether art, music or gaming. Now that they’re centimillionaires and poised to become billionaires, they have other worries: competitors, fraudsters and the next crypto crash.
Enduring Relations
The implementation of IA-CEPA amid the pandemic signifies the Indonesia-Australia’s commitment to recover and counter future challenges together.
Sweet Success
Steven Erwin envisions Unifam to become a major global player in the confectionery and F&B industry.
Marathon Man
Across America, scores of municipal pension funds remain scandalously underfunded. But not the pension fund of Tampa’s police and firemen, thanks in large part to JAY BOWEN, whose no-frills approach to stock picking has protected and served them for more than 45 years.
Gold Rallies on Inflation Fears
During September the price of gold rallied to $1,868 per ounce following the release of figures on US inflation by the Bureau of Labor Statistics which indicated that, as of September, CPI inflation had rocketed to 6.2%, above the 5.8% which economists had been predicting.
Set Off to A New Start
Bank Aladin has two main ingredients for success: establish trust and offer better customer experiences.
The Daily Intake
YOUVIT plans to invest further into marketing and grow into one of the leading vitamin brands in Indonesia.
THE CROESUS OF CRYPTO
FTX COFOUNDER SAM BANKMAN-FRIED BUILT A $22.5 BILLION FORTUNE BEFORE HIS 30TH BIRTHDAY BY PROFITING OFF THE CRYPTOCURRENCY FRENZY—BUT HE’S NOT A TRUE BELIEVER. HE JUST WANTS HIS WEALTH TO SURVIVE LONG ENOUGH TO GIVE IT ALL AWAY.
